Question
Are interleukin-6 antagonists effective in decreasing mortality among persons hospitalized with COVID-19?
Conclusion
Based on this systematic review, it is unclear if IL-6 antagonists decrease mortality among persons hospitalized with COVID-19. Co-intervention with corticosteroids has muddied the waters, and the data so far are dominated by a single agent (tocilizumab). The other agents do not appear to be effective.
Recent Posts
- Surgery is no better than nonoperative treatment for Achilles tendon rupture in adults
- Another study fails to find PRP injections effective for adults with degenerative joint disease of the knee
- Short-term benefit from ultrasonography-guided steroid injection for Achilles tendinopathy
- How do ibuprofen, ketorolac, and diclofenac compare for the treatment of acute, nonradicular low back pain in adults?
- Is there an association between gastric cancer and the use of proton pump inhibitors?
Leave A Comment